Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04499391 · ClinicalTrials.gov registry record · NA

COVID-19 Project ECHO in Nursing Homes

A NA study of COVID-19, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
136
Enrollment target
1
Study location

NCT04499391: Completed NA study of COVID-19, sponsored by Milton S. Hershey Medical Center.

NCT04499391 is a NA study of COVID-19 that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 136 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04499391, a NA study of COVID-19, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

Nursing homes are ground zero for the COVID-19 pandemic. Nursing homes are ill-equipped for the pandemic; though facilities are required to have infection control staff, only 3% have taken a basic infection control course. Significant research has focused on infection control in the acute care setting. However, little is known about the implementation of practices and effective interventions in long-term care facilities.The investigators propose an intervention utilizing Project ECHO, an evidence-based telehealth model, to connect Penn State University experts with remote nursing home staff and administrators to proactively support evidence-based infection control guideline implementation. Our study seeks to answer the critical research question of how evidence-based infection control guidelines can be implemented effectively in nursing homes

Primary Outcome

Rate of COVID-19 infection in enrolled nursing homes, as measured by the cumulative 4-week incidence at study points for Confirmed COVID-19 cases per 1,000 residents

Conditions Studied

Interventions

  • OTHER Project ECHO

Study Locations (1)

Pennsylvania

  • Penn State College of Medicine, Penn State Milton S. Hershey Medical Center - Hershey

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2020-12-04
Est. Completion 2022-10-30
Phase NA
Milton S. Hershey Medical Center

396 total trials

What the finished NCT04499391 record still lists

NCT04499391 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Project ECHO is the first listed.

NCT04499391 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04499391 about?

NCT04499391 is a clinical study titled "COVID-19 Project ECHO in Nursing Homes". Nursing homes are ground zero for the COVID-19 pandemic. Nursing homes are ill-equipped for the pandemic; though facilities are required to have infection control staff, only 3% have taken a basic infection control course. Significant research has focused on infection control in the acute care setti...

What is the current status of trial NCT04499391?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2020-12-04. Estimated completion is 2022-10-30.

What conditions does trial NCT04499391 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04499391?

The interventions under investigation include: Project ECHO (OTHER).

Who is sponsoring clinical trial NCT04499391?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04499391 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04499391's enrollment target sits among peer trials

136 184th of 298 higher than 115 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04499391, the US trial registry maintained by the National Library of Medicine. NCT04499391 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.